S100A2 expression in cholangiocarcinoma cells is related to a high frequency of lymph node metastasis, advanced clinical stage, and poor patient survival rates in vivo [102]. This evidence concerns the gene S100A2 and metastatic malignant neoplasm in the lymph nodes.